Skip to main content Start main content


RiFood Research: Close to 90% of C-Section Babies Experience Illness Before the Age of 1, Scholars Recommend Continued Breastfeeding; Cesarbiotic Formula reduced the number of illness incidence, Boosts Disease Resistance by nearly Three-Fold

PolyU Study: Close to 90% of C-Section Babies Experience Illness Before the Age of 1 Scholars Recommend Continued Breastfeeding   Cesarbiotic Formula reduced the number of illness incidence, Boosts Disease Resistance by nearly Three-Fold     HONG KONG, 6 MAY 2024 - Two in five newborns in Hong Kong were delivered by C-section. The Hong Kong Polytechnic University (PolyU) study commissioned by Danone focuses on the long-term correlation between the eating habits of C-section babies and their growth needs. The study reveals that close to 90% of C-section babies have fallen ill before the age of one, and they fall ill more often. A comparison between C-section babies who consume different formulas for 12 months has shown that those who consume Cesarbiotic Formula reduced the number of times they fall sick, and boost disease resistance by nearly three-fold.   PolyU pointed out that breast milk is the best source of nutrition, including probiotics for infants. Probiotics help establish a healthy gut ecosystem and reduce the risk of illness. Dr Chiou Jiachi, Associate Director of the Research Institute for Future Food, Associate Professor for Department of Food Science and Nutrition at PolyU, said, “This is the first real-world study to understand the relationship between the feeding method and the development of the gut ecosystem. Hong Kong has one of the highest rates of C-section deliveries in Asia. We hope to provide useful information for the parents so their babies can develop a healthy gut ecosystem.”   The study revealed C-section babies consumed Cesarbiotic Formula in the first two weeks of life had more beneficial bacteria in the gut compared to C-section babies cosumed regular formula. The dysbiosis of gut microbiota may affect immune development in babies, making them more susceptible to illness. The study also found, C-section babies who consumed Cesarbiotic Formula for 12 months boost disease resistance by nealy three-fold. The findings also showed, babies consumed Cesarbiotic Formula, the chances of not experiencing upper respiratory diseases, gut diseases and allergies are higher than those who consume regular formulas. The likelihood of them taking antibiotics is lower than those who consume regular formulas.     Pediatrician Dr. Yim Sau Wing states: "Studies have pointed out that, compared to babies born through natural childbirth, babies delivered by C-section have a relatively higher risk of infection and illness. Babies born by C-section do not come into contact with the beneficial bacteria in the birth canal during the birthing process, leading to an imbalance in their gut microbiome - the harmful bacteria outnumber the beneficial bacteria, which can make them more susceptible to infections, allergies, respiratory tract issues, e.g. asthma and gastrointestinal conditions, such as diarrhea and constipation. Therefore, if we can increase and continuously supplement the beneficial gut bacteria in C-section babies, there is a chance to boost their immunity and reduce their frequency of getting sick."   "Breastmilk provides the best and most suitable nutrition and probiotics for babies. But if breastmilk is insufficient, parents can consider specialized formula containing the beneficial bacteria strains and prebiotics, which can help supplement the gut microbiota in C-section babies. Research shows this could help reduce their risk of illness and allergies. Studies have also found that even for C-section babies beyond 1 year old, supplementing with probiotics and prebiotics can enhance the balance of the gut microbiome, and this may help establish long-term immune protection. Each baby has different needs at different stages of growth, so it's recommended to consult a doctor to choose the appropriate feeding method," Dr. Yim added.[TK1]   In 2021, PolyU launched a study on infants’ health needs based on different delivery and feeding methods; the study is now in its third phase. In the first phase, the Bifidobacterial in C-section babies was almost nowhere to be found. Bifidobacteria is a crucial beneficial bacteria for promoting good gut health and proper immune development in babies. In the second phase, the study found that the effectiveness of different formula milk in supplying gut microbiota to C-section babies varies by up to 40 times. The third phase observed the growth condition of C-section babies for 12 months. It was discovered that those babies are more likely to fall ill. Compared to C-section babies consumed regular formula, those consumed Cesarbiotic Formula reduced the number of times they fall sick, and boost disease resistance by nearly three-fold.   # ‘Disease Resistance’ refer to reduce number of illness  


Blue Business webinar promotion instagram post 2000 x 1050 px

Dr ZHAO Xin receives Biomaterials Young Investigator Award

Dr ZHAO Xin receives Biomaterials Young Investigator Award. Congratulations to Dr ZHAO Xin, Member of the Research Institute for Future Food (RiFood), Research Institute for Intelligent Wearable Systems (RI-IWEAR) and Research Centre for Chinese Medicine Innovation (RCMI), Associate Professor in the Department of Applied Biology and Chemical Technology (ABCT), for receiving the 2024 Biomaterials Young Investigator Award. Dr Zhao’s research focuses on Translational Regenerative Medicine, where she integrates material science, cell biology, engineering and medicine, to develop solutions for modulating cell micro-environments, controlling cell behaviours and generating tissue-engineered organs, thus addressing critical clinical issues. Launched by the Society of Biomaterials together with international journals including Biomaterials and Materials Today, the award recognises and encourages early career researchers in biomaterials science with outstanding contributions to the field. An award ceremony will be held at the 12th World Biomaterials Congress on 26–31 May 2024 in Daegu, South Area. Dr Zhao will receive the award in person and share on her innovative research.




由理大未來食品研究院研發的「食物廢料衍生的新型3D打印材料」,將於2023年10月28日至11月5日在香港科學園舉行的「創新科技嘉年華2023」中展出。   未來食品研究院院長黃家興教授指出,食物廢料可簡單分為兩大類。他解釋說:「第一類是廚餘,主要由家居或食店產生;第二類是食品加工場產生的廢料,因食物及農業廢料是來自食品廠,不僅生產集中,而且成分較單一均勻。這類工業食物廢料,例子有咖啡渣、茶葉渣和薯仔皮等,我們展出的創新綠色技術就是針對咖啡渣和茶葉渣,將之轉化成新型3D打印材料。」   3D打印在近幾年非常流行,而熔融沉積成型(FDM)是一種最常用的3D打印技術。FDM能打印各種工具,其主要材料為塑料。黃教授表示他們創新的綠色技術能將咖啡渣及茶葉渣作為原料, 結合聚乳酸(PLA)製造出新型3D打印材料。他說:「這種由食物廢料衍生的新型3D打印材料能應用於FDM型3D打印機,當中含有高達50%的食物廢料而不影響其列印性能。該材料的拉伸強度為10–40 MPa,用途廣泛,例如生產模塊化傢俱和展示商品等。」   該種可持續的新型3D打印材料有非常好的延展性,能打印出減震結構。為確保符合低碳方針,新型的3D打印材料甚至可以進行定制,易於放大,在生產過程亦無需化學添加劑,碳足跡遠低於商用PLA 3D打印材料約36%。   團隊將與本地連鎖咖啡店合作,以其咖啡渣來製作3D打印的環保傢俱及展示商品。嘉年華中亦將會展示各式各樣由咖啡渣轉化成的3D打印成品。  


Research Excellence 2000  1050 px 1

未來食品研究院研發新型納米硒 助改善女性更年期後骨質疏鬆

10月20日為本年度「世界骨質疏鬆日」。同日,未來食品研究院院長兼食品科學及營養學系教授黃家興向傳媒介紹其團隊最新研發的「蟲草菌絲體Cs4多醣蛋白功能化納米硒」(Cs4-SeNPs),可有助於管理更年期後骨質疏鬆症。 硒是人體健康必需的微量元素之一,具有廣泛的生理功能。 在過去幾十年的大量研究表明,缺硒與大骨節病、骨量減少以及骨質疏鬆症有密切關係,揭示出硒在骨代謝中的重要角色。近年,利用納米技術獲得的納米硒,因其生物相容性高、毒性低和生物活性顯著而成為新的研究熱點。然而, 迄今有關納米硒與骨健康的研究仍鮮有報導。 研究團隊以蟲草菌絲體Cs4多醣蛋白作為穩定劑,成功製備出高穩定性的新型Cs4多醣蛋白功能化納米硒(Cs4-SeNPs)。研究發現,Cs4-SeNPs(10μM)能顯著地誘導前成骨細胞的增殖、分化以及骨礦化。更重要的是,團隊利用去卵巢小鼠(更年期骨質疏鬆症的動物模型)驗證了口服Cs4-SeNPs (25, 50 & 500 µg/kg BW/day) 6周後,能通過促進骨形成,減低骨流失和改善骨微結構,展現出顯著的體內骨保護作用。有關納米專利技術,曾獲得多個國際獎項, 研究結果最近發表於國際學術期刊Journal of Functional Foods(連結)。   研究團隊將繼續探討Cs4-SeNP的胃腸穩定性、腸道吸收率、代謝途徑等領域並期待未來與企業合作,進一步研發有關保健品及藥物。 網上報道: 香港電台 - 東方日報 - am730 - 大公報 - 文報告 -   閱讀論文:  


Research Excellence 2000  1050 px

理大研究:逾七成半剖腹產母親遇到哺乳困難 剖腹產嬰兒益菌量近乎零 不同配方奶粉建立腸道益菌效果差異超過40倍

香港,2023年6月27日 - 香港大約每五個初生嬰兒便有兩個經剖腹分娩。香港理工大學(理大)就剖腹產嬰兒建立早期腸道益菌情況進行研究,發現逾七成半(77%)採用剖腹分娩的母親曾遇到哺乳困難,包括較遲上奶及乳汁不足,當中近七成(69%)對此感到壓力,而需要選擇配方奶粉餵哺嬰兒。然而,調查發現就補足剖腹產嬰兒腸道益菌效果方面,不同配方奶粉差異高達 40 倍。 理大去年就不同分娩方式對腸道微生物發展進行本地首項專門研究,發現剖腹產嬰兒腸道內雙歧桿菌水平近乎零;雙歧桿菌是一種可協助嬰幼兒建立良好免疫力以及保持腸道健康的關鍵益菌,可透過餵哺補足。因此,理大今年進行第二階段研究,冀了解剖腹產嬰兒建立腸道益菌的有效方法。 母乳是最好且最適合為嬰兒提供包括益生菌等所需營養的來源。然而,研究發現採用剖腹分娩的母親往往遇到哺乳困難,需要選擇配方奶粉補足嬰兒的營養需要。配方奶粉即使未能完全取代母乳中的分泌型免疫球蛋白A、益生元和益生菌,以及賀爾蒙等營養,但仍可提供嬰兒成長的元素。 理大研究人員收集了75個分別接受15款配方奶粉餵哺的本地剖腹產初生嬰兒的糞便樣本,比較當中雙歧桿菌的數量。研究發現,不同樣本在一周後腸道內雙歧桿菌的數量可出現高達 40 倍差異。當中為剖腹產嬰兒專研的益生致親組合配方可最快補足益菌數量,在首周後已追至貼近接受母乳餵哺的順產嬰兒腸道益菌之水平,並一直持續至四周後。在十二周後,雖然不同樣本中的雙歧桿菌水平已大致相若,不過剖腹產益生致親組別的短雙歧桿菌的數量仍然處於明顯較高水平。 第2頁 理大食品科學與營養學系副系主任、未來食品研究院副院長邱家琪博士表示:「香港是亞洲區內剖腹分娩率最高的地方之一。因此,我們希望透過科研,了解剖腹產嬰兒的特別營養需要。我們的研究發現腸道益菌數量與餵哺方式息息相關,不同配方產品的效用會有明顯差異。雖然母乳是初生嬰兒最好的營養來源,但如因不同理由而需要餵哺配方奶粉,父母應了解不同餵哺方式所提供的營養成分,幫助剖腹產嬰兒及早建立良好的腸道微生物組成。」 兒科專科徐梓筠醫生指出,剖腹產嬰兒及早提升腸道益菌,可以增強剖腹產嬰兒的免疫力。徐醫生認為:「剖腹產嬰兒在出生過程中未有接觸母親產道,較少接觸媽媽的產道益菌,尤其是雙歧桿菌。雙歧桿菌是母乳、母乳餵養的嬰兒腸道和產道中最常見的有益細菌,有助嬰兒建立免疫力。剖腹產嬰兒的腸道微生態容易出現失衡,害菌比例較高,而益菌比例較少,嬰兒較多機會出現敏感及腸道問題,如腹瀉﹑便秘等,所以剖腹產嬰兒有特定的營養需要,需要及早補足益生菌。雖然母乳能提供最好及最適合嬰兒的營養和益生菌,但若然母乳不足,父母可以考慮選用為剖腹產嬰兒專研的配方。這類專研配方含有產道同類益菌種及益生元,能為嬰兒補充益菌來源,及早打好免疫基礎,科研實證可減少將來出現過敏、腹瀉及上呼吸道感染的機會 。研究亦指出,即使是一歲以上的剖腹產嬰兒,補充益生菌及益生元也有助他們建立長遠的免疫保護。如要需要,最好詢問醫生的意見。 」


DoRiFood appointed member of AC on FEH_Web Banner


未來食品研究院院長獲委任食物及環境衞生諮詢委員會成員 未來食品研究院院長兼食品科學及營養學系副教授黃家興博士,獲香港特別行政區政府委任為食物及環境衞生諮詢委員會成員,任期兩年,由2023年4月1日起至2025年3月31日止。 諮詢委員會於2000年4月1日成立,就食物安全及環境衞生事宜向政府提供意見。 香港特別行政區政府新聞公報:


RiFood Member Appointed as a member of Advisory Council on the Envrionment ACE 1050x2000


✨👏🏼恭喜本研究院曾超華教授獲委任為環境諮詢委員會新成員!👍🏼 政府於二零二二年十二月三十日公布委任十一名環境諮詢委員會新成員,任期兩年,由二零二三年一月一日起至二零二四年十二月三十一日。 再一次恭喜曾超華教授憑籍傑出的科研實力榮任要職,並期望曾超華教授於制定環境及保育政策方面作出寶貴貢獻!👍🏼 更多資訊: #香港理工大學 #未來食品研究院 #曾超華教授 #環境諮詢委員會 #環諮會


RiFood Member Elected as Fellow of the Royal Society of Chemistry 2000X1050


恭喜本研究院曾超華教授獲選為英國皇家化學學會會士。英國皇家化學學會是匯集世界各地傑出化學家的權威化學學術團體,致力推動化學科學發展並嚴格把控化學科研領域的專業標準。 該會會士頭銜授予在化學科學研究領域取得傑出成就和為推動化學科學發展做出卓越貢獻的科學家。這項榮譽表彰了曾教授在工程學,環境及生態學的傑出成就,再一次向曾教授致以衷心的祝賀!


Breastmilk Press Conference 2000x1050


本院最新研究發現,香港哺乳媽媽普遍的水果及蔬菜攝取量均少於建議水平,其飲食與母乳內的營養水平,尤其是類胡蘿蔔素及多酚等植物營養素含量有顯著關係。🥕 邁向下一階段,本院研究團隊已開展新一項研究項目——「有營童行」,招募約 100 對哺乳期媽媽及其嬰兒進行為期一年的研究,進一步研究哺乳媽媽飲食習慣對其母乳營養素、嬰兒腸道菌群的組成及其成長的影響。🤱  有關「有營童行」研究計劃 過往有研究指出,母親飲食中的植物營養素或可調節母乳成分,從而影響受母乳餵哺的嬰兒成長,包括腸道健康。然而,亞洲地區包括香港的研究證據相當有限。為收集更多可靠的科學數據,為公眾提供實用的營養策略以提升母乳營養成分,現誠邀各位準媽媽及新生寶寶的母親參與未來食物研究院的項目「有營童行」。參與計劃的母親們可以獲得多項優惠,包括免費飲食習慣評估、母乳成份報告等,個人資料絕對保密。名額有限,額滿即止。 研究詳情及登記: 填寫以下報名表格: 查詢: 電話:3400 8806 WhatsApp:6677 8743 電郵 備註:整個評估程序已通過香港理工大學倫理委員會的審批。 本院於12月12日召開記者招待會發佈研究結果,更多詳情:  📝媒體報導: 香港電台: (英文); (中文) 英文虎報: (英文) Mirage News:英文) AM730: 文匯報:   香港01: 巴士的報: 點新聞: 世界新聞網: #PolyU #PolyURiFood #PressConference #Research #Breastmilk #Breastfeeding #理工大學 #理大未來食品研究院 #記者招待會 #母乳 #母乳餵哺 #有營童行


Orange Playful Fruit Fun Facts Instagram Post

理大未來食品研究院兩位成員獲選為「2022 年最廣獲徵引研究人員」

【有你同行—飲和食德.健康版】 本研究院督導委員會成員之一, 黃文秀教授於上星期五的港台節目 #有你同行 —《飲和食德.健康版》分享咗好多關於健康飲食嘅小貼士啊~ 想聽嘅朋友仔可以去下面網址重温返啦! 25/11 第二部份 17:30 – 18:00 黃文秀教授 《飲和食德.健康版》 — 想食得健康、低鹽及低糖,要如何選擇? #有你同行 #飲和食德健康版 #香港理工大學 #理大未來食品研究院 #理大 #香港電台 #Standbyme #PolyU #PolyURiFood #RTHK